Study Conduct

Survey: Need for increased consumer clinical trials education

Wednesday, March 2, 2016

SubjectWell, provider of a risk-free patient recruitment marketplace for clinical trials, has released its report on consumer perceptions of clinical trials. The SubjectWell Survey of Clinical Trial Awareness and Attitudes reveals significant education is still needed around the existence of clinical trials. Half of those surveyed (50%) had never heard of clinical trials, and only 31% felt confident or very confident that they would know how to get information about clinical trials. 

[Read More]

DrugDev launches clinical site activation SaaS technology

Wednesday, February 24, 2016

DrugDev has added technology features to its platform for clinical trial optimization with its new site activation module, which can reduce startup time from months to weeks. DrugDev’s site activation technology, now available to customers directly as a SaaS solution in addition to traditional outsourcing, enables companies to enhance efficiency, improve site relationships and reduce the time spent on startup activities by at least 20%.

[Read More]

BSI, ACRES develop global accreditation standards for clinical research sites

Tuesday, February 23, 2016

London-based British Standards Institution (BSI), which promotes excellence through standards development for business processes globally, and Massachusetts-based Alliance for Clinical Research Excellence and Safety (ACRES), a multi-sector collaborative building a global system for clinical research, have announced a major strategic partnership to promote excellence and improve quality and efficiency in medical product development worldwide.

[Read More]

Worldwide Clinical Trials marks Rare Disease Day with trial design webinar

Friday, February 19, 2016

Rare Disease Day, set for February 29, is intended to raise awareness around the world about rare diseases and their impact on patient lives. Worldwide Clinical Trials will mark the day with a free webcast that demonstrates new perspectives on the study of rare diseases, highlighting the need for the industry to rethink its approach to clinical trial design and execution within this complex area of medicine.

[Read More]